Evidence map›Paper›PMID 40401542›Full record

ArticleAlcohol and alcoholism (Oxford, Oxfordshire)2025

Motivation, self-efficacy, and identity-double-edged swords for relapse prevention in patients with alcohol related cirrhosis.

Christopher Oldroyd, Tamar Avades, Graham P Martin, Caitlin Notley, Michael E D Allison

Abstract read
In one paragraph

Article in Alcohol and alcoholism (Oxford, Oxfordshire), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Christopher OldroydUniversity of Cambridge, Cambridge University Hospitals NHS Foundation Trust, Cambridge Liver Unit, Addenbrooke's Hospital, Hills Rd, Cambridge, Cambridgeshire, CB2 0QQ, United Kingdom.ORCID 0000-0002-4934-8345
Tamar AvadesHepatology Research Group, University of Plymouth, Plymouth, Devon PL4 8AA, United Kingdom.
Graham P MartinThe Healthcare Improvement Studies Institute, University of Cambridge, Strangeways Research Laboratory, 2 Worts' Causeway, Cambridge, Cambridgeshire, CB1 8RN, United Kingdom.
Caitlin NotleyAddiction Research Group, University of East Anglia, Norwich Research Park, Norwich, Norfolk NR4 7TJ.ORCID 0000-0003-0876-3304
Michael E D AllisonCambridge University Hospitals NHS Foundation Trust, Cambridge Liver Unit, Addenbrooke's Hospital, Hills Rd, Cambridge, Cambridgeshire CB2 0QQ, United Kingdom.

Funding

Health Foundation's grant to the University of Cambridge for The Healthcare Improvement StudiesNational Institute for Health and Care Research Doctoral NIHR302571
6 · The paper itself

Abstract

BACKGROUND AND

aimsDespite the critical importance of alcohol abstinence for patients with advanced liver disease, rates of returning to alcohol remain high and engagement with relapse prevention interventions is low. This study explores the potential barriers to relapse prevention in these patients.

methodsSemi-structured interviews were conducted with patients who had alcohol-related cirrhosis or alcohol-associated hepatitis. Interviews took place during a hospital admission. The study methodology was informed by a constructivist grounded theory approach.

resultsThirty-three participants were recruited from two sites. Participants had a mean age of 52 (range 30-60) and there were 10 female participants (30%). Most participants were actively drinking alcohol at time of admission (n = 26) and 16 participants were interviewed during their index admission with alcohol-related liver disease.A renewed understanding of the health risk posed by future alcohol made participants confident that they would not return to alcohol use and participants felt that the most important factor in relapse prevention was their own motivation and willpower. However, many rejected the identity label of 'alcoholic' and drew a distinction between themselves and 'bad drinkers'. These factors combined to create a barrier to relapse prevention therapies, since participants felt these were neither appropriate nor necessary for them.

conclusionsEnhanced self-efficacy, a belief in the importance of willpower, and a rejection of the alcoholic identity can together act to reduce engagement in relapse prevention in patients with advanced liver disease. Relapse prevention interventions should be reframed or redesigned to address these barriers.

Indexed as

Liver Cirrhosis, AlcoholicMotivationSecondary PreventionSelf EfficacyAdultAlcohol AbstinenceAlcohol DrinkingFemaleHumansMaleMiddle AgedRecurrenceabstinencealcoholcirrhosishepatitisrelapse

Identifiers

PMID40401542
PMCPMC12096075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.